Jump to Navigation

Facebook Connect

User login

For Registered Nurses and Nurse Practitioners Only: Provide appropriate care and counsel for patients and their families

  Peter P. Toth, MD, PhD, FCCP, FAHA, FACC, Program Chairman Director of Preventive Cardiology CGH Medical Center Sterling, IL Professor of Clinical Family and Community Medicine University of Illinois School of Medicine Peoria, IL Professor of Clinical Medicine... more

5
Average: 5 (1 vote)

The NLA is pleased to announce a NEW online CME/CE activity entitled, The Emergent Science of HDL and its Metabolism: Mechanistic Understanding of CETP Antagonism and Beyond. This NLA- and Rockpointe-endorsed activity includes selected presentations and expert faculty commentary from the satellite... more

5
Average: 5 (1 vote)

To participate in this activity, please watch the videos below. The total run time for all videos together is approximately 70 minutes. Once you have watched the videos, you can click the "Take Activity" below to take a post-test and evaluation; and upon passing these requirements, you... more

0
No votes yet

The NLA is pleased to announce the new Virtual Patient Management Series (vClinicTM) program vClinic: Rosa Visit 1. This new vClinic will address key knowledge and competency gaps for optimizing adherence to lipid-modifying therapies, in order to reduce the risk of morbidity and mortality from... more

0
No votes yet

The NLA is pleased to announce the new Virtual Patient Management Series (vClinicTM) program vClinic: Rosa - Visits 2 & 3. This new vClinic will address key knowledge and competency gaps for optimizing adherence to lipid-modifying therapies, in order to reduce the risk of morbidity and... more

0
No votes yet

Chapter 5: CETP as a Therapeutic Target This slide module, CETP as a Therapeutic Target will address the following topics: Discovery of CETP Functions of CETP and the relationship to CAD risk Genetics of CETP Effects of CETP inhibition on atherosclerosis in animal models... more

0
No votes yet

Non-CETP Novel Targets and New Drug Therapies Targeting HDL This slide module entitled Non-CETP Novel Targets and New Drug Therapies Targeting HDL, will highlight the various drug therapies in development for targeting HDL The module will present the differences amongst the various... more

0
No votes yet

Suparna Visits 1 and 2: Cardiovascular Disease Risk Assessment and Management of a Woman with Metabolic Syndrome In this case, we will review the history of a 22-year old woman of Asian-Indian descent who presents with metabolic syndrome. Patient assessment and management during 2... more

0
No votes yet

Mike Visits 1-3: Cardiovascular Risk Assessment and Management of a Male Diabetic Patient with Multivessel CAD and Low HDL-C In this case, we will review the history of a 57-year old male patient with low HDL-C and progressive, unstable CAD. He has been slow to take his risk factors and... more

0
No votes yet

Chapter 1: Epidemiology and Nomenclature This slide module will give an overview of the epidemiology of HDL, the history of HDL-C as a therapeutic target, how HDL-C is associated with CVD Outcomes and an overview of measures of HDL quantity. FACULTY Chair Peter... more

0
No votes yet

Pages

Subscribe to For Registered Nurses and Nurse Practitioners Only: Provide appropriate care and counsel for patients and their families


by Dr. Radut.